The most common side effects reported in T-DM1 were anemia, thrombocytopenia, and elevated serum concentrations of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) [23,97]. This evidence concerns the gene GPT and Thrombocytopenia.